The regulations are short and tightly drafted, but several practical pitfalls arise from what the instrument delegates, omits or folds into other instruments. Below are the main "gotchas" drawn from the text.
Record keeping is specified but delegated to a Ministerial scheme (reg 5(a)). The person responsible must "make and keep such records relating to the giving of consent as may be required under a scheme determined from time to time by the Minister and published in the Gazette." The regulation does not specify content, format, retention period, or enforcement steps. Practitioners therefore cannot rely on the regulations alone to know what records are required; the applicable Ministerial scheme must be consulted in the Gazette. Failure to check the current Ministerial scheme is a practical trap.
No penalty specified in the regulations for failure to keep records. Regulation 5(a) demands record keeping but the regulations do not itself specify a penalty or enforcement mechanism should the person responsible fail to comply. Enforcement may be via the Act, the Tribunal, or the Ministerial scheme, but the regulations leave that link opaque. Parties should therefore check the Act and the Ministerial scheme for enforcement provisions; practising advisers should not assume existence or non‑existence of sanctions without checking those instruments.
"Person responsible" is not defined in the regulations. Regulation 5(b) relies on the Act’s definition (paragraph (d) of section 14(1)), but the regulations do not restate who qualifies. This is a frequent source of confusion in practice where capacity, hierarchy of decision‑makers, and substitution are contested. Advisers must refer to the Act to determine the identity of the person responsible before applying reg 5 duties and prohibitions.
Prohibition on consenting to chemical restraint is limited in scope (reg 5(b)). The prohibition applies to a person responsible "contemplated by paragraph (d) of the definition of person responsible in section 14(1) of the Act" and concerns administration of drugs "principally for the purpose of controlling the behaviour of the patient." The restriction is therefore both actor‑specific and purpose‑based. That dual limitation means situations where drugs are administered primarily for clinical reasons but have ancillary behavioural effects may fall outside the prohibition. Assessing the "principal purpose" will be fact dependent and could be contested.
Delegation standard for the Public Advocate is subjective (reg 6(1)). The Public Advocate may only delegate mediation functions if "satisfied that the person has suitable qualifications and expertise in mediation." The regulation does not specify objective criteria for "suitable qualifications and expertise," so reviewability may focus on whether the Public Advocate's satisfaction was reasonable. Delegation in the absence of documented assessment of qualifications could be vulnerable to challenge.
Privileges and immunities for mediators may be broader than anticipated (reg 6(2)). Mediators delegated by the Public Advocate have "the same privileges and immunities as a member of the Tribunal" under the SACAT Act 2013. That grants significant legal protection to delegates. Parties should be aware that mediator conduct under delegation is afforded robust legal protections, which affects prospects for civil claims arising from mediation activities.
Time limits and exhaustive disclosure on referrals (reg 7). When the Public Advocate or Tribunal refers a matter, the referring party must do so within seven business days and provide written reasons, a summary, contact details and "all other information relevant to the matter that is in the possession" of the referrer. That phrase is broad and creates a heavy disclosure duty. Failure to compile a complete package within the seven business day window may be prejudicial in Tribunal proceedings and could be the basis of procedural complaints. Organisations should prepare to collate comprehensive files promptly.
Triangular prohibition on Tribunal referral if mediation already occurred (reg 7(3)). The Tribunal may not refer a matter to the Public Advocate if mediation under section 18C has already happened. This can create procedural dead ends if parties expect iterative referral‑mediation cycles. Practitioners need to map prior mediation history carefully before seeking or responding to referrals.
Fees appear minimal but may not be exhaustive (reg 8 and Sch 1). Schedule 1 lists only one fee: nil for an application under section 18C. That removes an upfront fee for mediation application, but the Schedule does not list other potential fees that could apply elsewhere under the Act or other statutes. Parties should not assume that all Tribunal or administrative processes are free based on the single nil entry.
Cross‑legislative definitions matter (reg 4). Including ambulance services and paramedics in the Act’s "health practitioner" definition imports definitions from the Health Care Act 2008. Practitioners should verify authorised providers and definitional scope in that Act to determine who is captured. There is a risk of assuming every ambulance attendant is covered when the Health Care Act’s authorisation status may matter.
In short, the main practical risks are reliance on delegated content in the Ministerial scheme, absence of explicit regulatory sanctions, subjective delegation criteria, broad disclosure duties on referrals, and definitional dependencies on other Acts. Each of these requires checking the Act and the relevant Gazette‑published Ministerial instruments and maintaining administrative systems to ensure timely, complete referral packages and record keeping.